RxDoctor Payments Data

Stephen Pieper, MD

Clinical Cardiac Electrophysiology · Saint Louis, MONPI 1144214297

Payments from drug & device makers

What this record shows

6 manufacturers reported payments, led by Abbott at 57.0% of the total. Reporting peaked in 2020 at $3,677 and has fallen 88.6% since, to $419 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MO, where the typical reported total is $14,594.

$7,508in general payments, 2019–2025

Across 74 payments — averaging $101.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Impulse Dynamics (USA) Inc.$3K
  • Biotronik Inc.$209
  • Abiomed$144
  • Pfizer$58
  • Medtronic$13

What the payments were for

  • Consulting fees$3,37545%
  • Food & beverage$4,13355%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott25$4,279
Impulse Dynamics (USA) Inc.42$2,804
Biotronik Inc.4$209
Abiomed1$144
Pfizer1$58
Medtronic1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,508 in reported general payments places this provider in the 35th percentile of 74 clinical cardiac electrophysiology providers in Missouri.

See all clinical cardiac electrophysiology providers in Missouri

Medicare billing

Part B allowed, 2024
$118,069
Medicare patients
465
Services billed
2,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban228$251,088
XareltoRivaroxaban52$54,057
MultaqDronedarone Hcl26$20,026
Dofetilide19$4,522
Amiodarone Hcl84$2,344
Metoprolol Succinate66$788
Diltiazem 24hr Er (Cd)Diltiazem Hcl25$403
SotalolSotalol Hcl18$311
Carvedilol44$288
Digoxin11$215
Atenolol26$168
Metoprolol Tartrate16$75

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$58$251,088228 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 74 clinical cardiac electrophysiology providers in Missouri.

Other clinical cardiac electrophysiology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →